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The role of melanin in nicotine uptake and metabolism has received little attention. Because nicotine has been
shown to accumulate in tissues containing melanin, exploring links between melanin and nicotine may provide
additional clues to understanding smoking behavior and disease effects. To examine the scientific literature on the
relationship between melanin and nicotine, we conducted a PubMed search. We also searched online archives of
internal tobacco industry documents. We retrieved and reviewed 82 published research papers related to melanin
and nicotine or melanin and metabolism of other drugs, and 150 relevant internal tobacco industry documents. The
published literature suggests that nicotine may accumulate in human tissues containing melanin and this retention
may increase melanin synthesis. Existing research on the relationship between melanin and nicotine lacks an
adequate consideration of this relationship’s potential impact, if any, on nicotine metabolism, level of nicotine
dependence, and ability to quit smoking. Differential accumulation of nicotine in melanin-containing tissues could
have implications for individuals with high levels of melanin.
Introduction
Melanin’s relationship to nicotine has been studied
inadequately to date. Melanin is a pigment that gives
color to the skin, eyes, and hair (Freedberg &
Fitzpatrick, 1999, p. 936; Hedin & Larsson, 1978).
Its amount in the skin determines the level of
pigmentation observed in individuals (Diffey,
Oliver, & Farr, 1984; Kollias & Baqer, 1986;
Shriver & Parra, 2000). Research on nicotine’s
distribution in animal tissues that was conducted
during the 1970s revealed an accumulation of
nicotine in melanin-containing tissues (Larsson,
Olsson, Szuts, & Ullberg, 1979; Lindquist &
Ullberg, 1974; Waddell & Marlowe, 1976).
Melanin is produced exclusively inside melano-
somes, which are synthesized by highly specialized
cells called melanocytes (Baker & Joseph, 1960;
Freedberg & Fitzpatrick, 1999, p. 209; Seiji,
Fitzpatrick, Simpson, & Birbeck, 1963). It is well
established that no racial or ethnic differences exist in
the number of melanocytes (Soames, 1974; Squier &
Waterhouse, 1967; Staricco & Pinkus, 1957; Szabo,
1954; Zelickson, 1967). Those components having a
significant role in the final appearance of human
skin color are total melanin content, melanin
composition, and melanosome size (Alaluf et al.,
2002; Ito & Wakamatsu, 2003; Szabo, 1959). The
degree of pigmentation results from a complex
process that includes melanin synthesis, the subse-
quent transfer of melanin from the melanosomes to
the neighboring keratinocytes (another population of
cells located in the skin and oral mucosa), and the
distribution of these melanin-loaded keratinocytes
(Boissy, 2003; Hearing, 1999; Hedin & Larsson,
1984; Olson, Nordquist, & Everett, 1970; Schroeder,
1969; Squier & Waterhouse, 1967).
There are two types of skin pigmentation.
Constitutive skin color, which is determined geneti-
cally and not directly affected by sun exposure, has
photoprotective properties (Kollias, Sayre, Zeise, &
Chedekel, 1991) and is seen in areas of the body that
are habitually shielded from light (Freedberg &
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Fitzpatrick, 1999, p. 194). Facultative skin color, or
‘‘tan,’’ is induced by direct exposure of the skin to
ultraviolet radiation (Fitzpatrick, Pathak, &
Shiseido, 1974), hormonal changes, or disease
(Freedberg & Fitzpatrick, 1999, p. 194). When
compared with lighter skin, darker skin tends to
have more and larger melanosomes of the type that
are individually bound within a membrane. Lighter
skin has less melanin than darker skin and contains
smaller melanosomes (Alaluf et al., 2002; Quevedo,
Fitzpatrick, Pathak, & Jimbow, 1975), which tend to
be aggregated and bound in groups as complexes
(Konrad & Wolff, 1973; Olson, Gaylor, & Everett,
1973; Thong, Jee, Sun, & Boissy, 2003; Toda,
Pathak, Parrish, Fitzpatrick, & Quevedo, 1972).
Melanin-containing tissues have been located in
various parts of the human body outside the skin
complex, including in the heart, lungs, liver, brain
(Altschule & Hegedus, 1976), lymphocytes
(Wassermann, 1964), and inner ear (Breathnach,
1988). The black-brown pigment located in the
human central nervous system is called neuromelanin
(Wassermann, 1965) and has been shown to accu-
mulate in the substantial nigra of the brain during
aging (Bogerts, 1981; Cotzias, Papavasiliou,
Vanwoert, & Sakamoto, 1964; Graham, 1979;
Mann & Yates, 1974). Melanocytes have been
located in nasal mucosa (Zak & Lawson, 1974), the
oral cavity (Laidlaw & Cahn, 1932), the larynx
(Goldman, Lawson, Zak, & Roffman, 1972), and
esophagus (De La Pava, Nigogosyan, Pickren, &
Cabrera, 1963). In dark-skinned ethnic groups,
melanin also has been found in the lymphatic system
draining the skin (Okuma & Seiji, 1973).
Method
To better understand nicotine’s accumulation in
melanin-containing tissues, we examined literature on
the relationship between melanin and nicotine. A
literature search for articles published in English
pertaining to the accumulation of nicotine in animal
tissue was conducted on PubMed. The studies were
published between 1974 and 2003. Searches also were
performed for additional authors and for studies
identified in the references of the initially selected
articles. We combined MeSH search terms melanins,
pigments, melanocytes, melanosomes, autoradiography,
or hair with nicotine, cotinine, smoking, tobacco,
cigarette (non-MeSH term), or drugs. The search
yielded 982 citations. We screened these to identify
studies that presented research findings or discussed
possible mechanisms of the accumulation of nico-
tine or other drugs in human or animal melanin-
containing tissues. We augmented this search by
reviewing studies that addressed melanin’s interactions
with drugs other than nicotine. This resulted in a set of
264 articles. After eliminating duplicates, reviews,
letters, those not written in English, and articles found
not to be relevant, a total of 82 publications were
selected for this review, including 43 articles addressing
drug-melanin interactions. Table 1 shows the 38
studies relevant to melanin and nicotine. Articles on
neuromelanin were not included in the review because
neuromelanin is structurally distinct.
In addition, we conducted searches of internal
tobacco company documents made publicly available
through the 1998 Master Settlement Agreement
(available in the Legacy Tobacco Documents
Library at www.legacy.library.ucsf.edu; Balbach,
Gasior, & Barbeau, 2002; Malone & Balbach,
2000). We combined the terms melanin and nicotine
in our initial search of the tobacco documents
archives. We then used a ‘‘snowball approach’’ to
conduct further searches on names of individuals
identified in pertinent documents and materials from
their files. We reviewed approximately 150 internal
company documents. We also reviewed background
literature on melanin.
Results
Autoradiographic studies
The distribution of nicotine in the body has been of
interest to investigators since 1851 (U.S. Department
of Health and Human Services [USDHHS], 1988).
However, it was not until the 1960s that a team of
Swedish researchers, using whole-body autoradio-
graphy (Ullberg, 1954), would be able to visualize
nicotine’s distribution in animal tissue (Hansson &
Schmiterlow, 1962). In 1972, based on in vitro
experiments that had provided evidence that nicotine
accumulated in tissues containing melanin, the
Swedish researchers conducted autoradiographic
studies on pigmented animals ‘‘to investigate whether
this affinity [attraction of nicotine for melanin] can
be observed in vivo and if so how persistent’’
(Ullberg, 1972). This research continued for the next
several years, providing additional evidence that
nicotine accumulated differentially in melanin-
containing tissues (Larsson et al., 1979; Lindquist
& Ullberg, 1974). Additionally, research on animal
fetuses suggested that fetal tissues containing mela-
nin might be more sensitive to nicotine than the
corresponding adult structures (Larsson et al., 1979;
Szuts et al., 1978).
During the 1970s in the United States, Waddell
and Marlowe (1976) also used whole-body auto-
radiography to study nicotine distribution in animal
tissue. Though they noted no differences between
pigmented and albino mice in the pattern of how
nicotine was distributed in the bronchi, kidney, urine,
salivary gland, liver, bile, and contents of the
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Table 1. Summary of melanin and nicotine research.
Autoradiography Year Author Summary of findings related to melanin
Mouse 1974 Lindquist & Ullberg Strong and persistent accumulation of nicotine in tissues containing melanin.
Mouse 1976 Waddell & Marlowe Nicotine has a remarkable accumulation in melanin-containing tissues.
Mouse 1978 Szuts et al. Consistently high concentration of nicotine found in melanin-containing tissues; melanin
has lower binding capacity with cotinine than it does with nicotine.
Mouse 1979 Larsson et al. Nicotine accepted as a precursor in the formation of melanin; uptake of nicotine likely to
be higher in fetal melanin than in maternal melanin.
Mouse 1980 Brittebo & Tjalve NNN metabolites bind to melanin in eye and hair in vivo and in vitro.
Mouse 1980 Waddell & Marlowe NNN localizes in melanin-containing tissues; little probability that NNN metabolizes to
reactive metabolite.
Hamster 1983 Tjalve & Castonguay NNK and its metabolites bind to eye melanin; somewhat exceed the level in blood
Mouse 1984 Castonguay et al. Metabolites of NNN and NNK localized in eye melanin.
Marmoset monkey 1985 Castonguay et al. NNN and NNK accumulate in melanin of eyes and hair follicles of skin.
Miniature pig 1987 Domellof et al. NNN accumulates in melanin of eyes and skin.
Mouse and hamster 1996 Roberto et al. Pronounced retention of polycyclic aromatic hydrocarbons, e.g. benzo(a)pyrene, in
melanin-containing structures of eyes and hair follicles.
In vitro experiments Summary of findings related to melanin
Mouse tissue 1979 Larsson et al. Intact nicotine accumulation in newly formed melanin.
Toad and frog tissue 1986 Hedin & Larsson Nicotine activated amphibian dermal melanocytes.
In vitro 2001 Claffey et al. Explored drug (including nicotine)-melanin interactions. Nicotine has much tighter
association with melanin than did the other drugs tested in this study.
In vitro 2001 Dehn et al. Pigmentation influences drug incorporation into hair; study provides evidence of a
nicotine-melanin association.
Nicotine hair analysis: Human Summary of findings related to melanin
36 Japanese subjects 1993 Mizuno et al.a Concentration of nicotine in white hair was much lower than that in black hair collected
from same subject.
22 Japanese subjects 1993 Uematsu Concentration of nicotine in white hair was much lower than that in black hair collected
from same subject.
26 Japanese subjects 1995 Uematsu et al. Slow dissociation of nicotine from melanin in hair when compared to other drugs; higher
nicotine content in black hairs than in white hairs of same subject.
80 European male subjects 1996 Zahlsen et al. Relative affinity of nicotine for hair pigments is not known.
150 mother-child pair hair samples 2003 Pichini et al. Hair nicotine concentration of newborns can be due to differences including melanin
content.
Nicotine hair analysis: Animal Summary of findings related to melanin
Rat 1993 Mizuno et al.a Mean concentration of nicotine in whitish hair was lower than that in brown hair collected
from same animal.
Rat 1995 Gerstenberg et al. Nicotine concentrations were 20 times higher in pigmented than in unpigmented hair.
Mouse 1999 Stout & Ruth Explored drug (including nicotine)-melanin interactions. Results suggest darker-haired
individuals are likely to accumulate and retain more drugs in their hair. Systemically
administered drugs are more strongly retained in forming hair than are drugs from
environmental exposure.
Mouse 2000 Claffey et al. Results demonstrate a significant interaction of nicotine with melanin.
Clinical and histological examination Summary of findings related to melanin
214 Swedish subjects 1977 Hedin Increased oral melanin pigmentation in 25.5%–31.0% of smokers.
30,118 Swedish subjects 1982 Axell & Hedin Presence of oral melanin pigmentation among tobacco smokers was 21.5%, compared
with 3% among non–tobacco users.
195 Japanese male subjects 1983 Araki et al. Increased oral melanin pigmentation in 17% of smokers and in 24% of smokers 4 years
later.
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stomach and upper intestine, they, too, noted an
intense localization of nicotine in the melanin of the
pigmented mice. ‘‘The black pigment in the eye, hair
follicles, and in the meninges of the brain had the
most intense accumulation of any site in this strain …
There was no accumulation of [radioactive nicotine]
in these sites in the [albino] strain’’ (University of
Kentucky, Tobacco and Health Research Institute,
1973). Their subsequent research supported these
findings (Waddell & Marlowe, 1976, 1980).
In one study nicotine was shown to be retained in
melanin-containing tissues for up to 30 days after a
single intravenous injection (Lindquist & Ullberg,
1974). Other studies also found accumulation and
long-term retention of nicotine in melanin-containing
structures (Barza, Kane, & Baum, 1979; Lindquist &
Ullberg, 1975; Mizuno, Uematsu, Ishikawa,
Yoshimine, & Nakashima, 1997; Szuts et al., 1978).
Larsson et al. (1979) hypothesized that nicotine’s
retention in melanin-pigmented tissues involved
nicotine being accepted as a precursor in the
formation of new melanin, because of a structural
resemblance between melanin and nicotine’s main
precursor, indole-5,6-quinone. More recently, inves-
tigators have suggested that the melanin-nicotine
relationship may stem from irreversible bonding
(Claffey, Stout, & Ruth, 2001; Dehn, Claffey,
Duncan, & Ruth, 2001).
Nicotine hair analysis
Investigators have observed the role of melanin
pigmentation in the accumulation of various drugs,
including nicotine, in hair analyses (Claffey & Ruth,
2001; Hold, Hubbard, Wilkins, & Rollins, 1998;
Ishiyama, Nagai, & Toshida, 1983; Mizuno,
Uematsu, Oshima, Nakamura, & Nakashima, 1993;
Reid, O’Connor, Deakin, Ivery, & Crayton, 1996;
Rothe, Pragst, Thor, & Hunger, 1997; Sato,
Uematsu, Yamada, & Nakashima, 1993; Slawson,
Wilkins, & Rollins, 1998; Stout & Ruth, 1999;
Uematsu, Miyazawa, Okazaki, & Nakashima, 1992;
Uematsu, Sato, Fujimori, & Nakashima, 1990).
When a drug displays an affinity for melanin in the
hair, it also will have an affinity for the melanin
located in skin and other tissues (Harrison, Gray, &
Solomon, 1973).
More recently, researchers have been interested in
the use of hair as a potential biomarker to assess
systemic uptake and accumulation of nicotine
(Gerstenberg, Schepers, Voncken, & Volkel, 1995),
chronic exposure to second-hand smoke (Dimich-
Ward, Gee, Brauer, & Leung, 1997; J. J. Jaakkola,
Jaakkola, & Zahlsen, 2001; M. S. Jaakkola &
Jaakkola, 1997; Klein & Koren, 1999; Nafstad
et al., 1995; Pichini, Altieri, Pellegrini, Pacifici, &
Zuccaro, 1997; Woodruff, Conway, Edwards, &T
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Hovell, 2003), and smoking status (Uematsu,
Mizuno, Nagashima, Oshima, & Nakamura, 1995).
These studies and others have indicated that the
interaction of drugs with melanin has implications in
assaying hair samples (Potsch, Skopp, & Moeller,
1997) and interpreting results (Hold et al., 1998).
Compared with lightly colored hair, dark hair
accumulates and retains larger amounts of nicotine
(Stout & Ruth, 1999; Uematsu et al., 1995),
consistent with earlier findings of nicotine’s affinity
with and slow dissociation from melanin (Mizuno
et al., 1997). An extensive literature review on the use
of hair as a biomarker for exposure to tobacco smoke
included a discussion of systemic and external hair
uptake of nicotine and other drugs, and acknowl-
edged the need for further studies to investigate the
relationship between hair melanin and nicotine
uptake (Al-Delaimy, 2002).
Clinical and histological examinations
‘‘Melanosis gingivae,’’ melanin pigmentation in the
mouth, is often seen in individuals of dark-skinned
ethnic groups (Becker, 1969; T. Brown, 1964;
Dummet, 1966) but seldom seen among White
Europeans (P. L. McCarthy & Shklar, 1964).
However, ‘‘smoker’s melanosis’’ is a phenomenon
that has been reported among tobacco smokers from
fair-skinned and dark-skinned ethnic groups (Axell
& Hedin, 1982; Hedin, 1977; Ramer & Burakoff,
1997; Unsal, Paksoy, Soykan, Elhan, & Sahin, 2001).
The amount of this increased oral pigmentation is
directly correlated with the number of cigarettes
consumed each day (Axell & Hedin, 1982). Although
several diseases are characterized by increased
pigmentation in the oral mucosa (P. L. McCarthy
& Shklar, 1964), smoker’s melanosis is hypothesized
to be either the result of nicotine’s ability to stimulate
melanocyte activity and melanin production or
related to the binding of melanin to noxious
substances in the tobacco smoke (Hedin, 1977,
1991; Iwata, Inui, & Takeuchi, 1981; Sarswathi,
Kumar, & Kavitha, 2003; Taybos, 2003).
Tobacco-specific carcinogens
Nicotine is not the only substance found in tobacco
that has been shown to accumulate in melanin-
containing tissues. The N-nitrosamines N9-nitroso-
nornicotine (NNN) and 4-(methylnitrosamino)-1-(3-
pyridyl)-1-butanone (NNK) are the most abundant
carcinogens in tobacco smoke (Hoffmann, Adams,
Brunnemann, & Hecht, 1979; Keeney, Waddell, &
Perraut, 1982) and have been shown in animal
studies to accumulate in melanin-containing tissues
(Brittebo & Tjalve, 1980, 1981; Domellof et al., 1987;
Iwata et al., 1981; Tjalve & Castonguay, 1983;
Waddell & Marlowe, 1980). These tobacco-specific
carcinogens have been shown to lead to the devel-
opment of lung adenomas and squamous cell
carcinomas when administered orally, topically,
subcutaneously, or intraperitoneally (Carbone,
1992; Hecht, 1999; Hecht et al., 1993). It has been
hypothesized that NNN becomes carcinogenic when
its reactive metabolites interact with genetic material.
However, if the melanocytes have an enzymatic
capacity to degrade the NNN, then high local
concentration of NNN, reversibly bound to melanin,
may constitute a hazard (Brittebo & Tjalve, 1980).
NNK metabolites have been shown to bind to the
tissues of nasal mucosa and lung, indicating NNK
metabolism has occurred in these tissues. Unbound
metabolites distribute in the body and reach various
tissues to eventually be excreted, primarily in the
urine. However, accumulation of tissue-bound meta-
bolites has been suggested to be correlated to the
susceptibility of some laboratory animals to carcino-
genicity of NNK (Castonguay, Tjalve, & Hecht,
1983).
The polycyclic aromatic hydrocarbons (PAHs) are
another group of tobacco-specific compounds.
Among the PAHs, benzo(a)pyrene is the most
extensively studied compound (Hecht, 1999). It is
listed among cigarette smoke carcinogens evaluated
by the International Agency for Research on
Cancer (IARC; Hoffmann & Hoffmann, 1997).
Benzo(a)pyrene also has been shown to accumulate
in melanin-containing tissues, and its presence in
these tissues may induce carcinogenesis (Roberto,
Larsson, & Tjalve, 1996). Its ability to induce lung
tumors upon local administration or inhalation is
well documented (IARC, 1972, 1983; Thyssen,
Althoff, Kimmerle, & Mohr, 1981; Wolterbeek,
Schoevers, Rutten, & Feron, 1995), and there is
sufficient evidence of its carcinogenicity in laboratory
animals and humans (Hoffmann & Hoffmann, 1997).
Benzo(a)pyrene increases the bioactivity of the
melanocytes (Iwata et al., 1981; Lindquist &
Ullberg, 1975), whereby human melanocytes in
culture have been found to convert benzo(a)pyrene
to its carcinogenic metabolite benzo(a)pyrene-7,8-
diol (IARC, 1985).
Perhaps problematic for smokers of mentholated
cigarettes is the fact that menthol combustion
produces benzo(a)pyrene (Schmeltz & Schlotzhauer,
1968) and smoking menthol cigarettes might generate
carcinogenic components responsible for lung cancer
(W. J. McCarthy et al., 1995). Smoking menthol
cigarettes may result in greater exposure to a
smoker’s respiratory tract and greater transfer of
tobacco smoke toxins into the pulmonary circulation
(Garten & Falkner, 2004). If smoking menthol
cigarettes results in exposure to benzo(a)pyrene and
its carcinogenic metabolite, these substances may
accumulate in melanin-containing tissues.
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Mechanisms of melanin-drug interactions
Understanding the mechanisms involved in how
other drugs interact with melanin may provide
additional insight into the interaction between
melanin and nicotine. Drugs travel via the arter-
iovenous or lymphatic circulation, thereby gaining
access to melanocytes (Harrison, Gray, & Solomon,
1974; Takahashi & Fitzpatrick, 1966). Depending on
its affinity for melanin, a drug will either bind
directly to melanin or become entrapped inside the
melanocyte during melanin synthesis (Potsch et al.,
1997). When a drug enters a melanocyte, it then
enters the melanosome and interacts with melanoso-
mal proteins. These structural proteins of the
melanosome are firmly associated with melanin
(Sharma, Wagh, & Govindarajan, 2002) and play a
role in entrapping drugs within the melanin granules.
These drug-entrapped melanin granules are then
carried outside of the melanocyte, where circulating
lymphocytes are capable of transporting them to
other sites (Ishizaki & Belter, 1960; Sundberg, 1956;
Wassermann, 1963, 1965).
Though not referring specifically to the drugs’
interaction with melanin-containing tissues, a 1929
human study demonstrated racial differences in how
several drugs affected pupil dilation. When compared
with the pupils of Whites, the pupils of dark-skinned
individuals were less responsive (Chen & Poth, 1929).
The investigators reported that the pigments inter-
fered with the penetration of the drugs. Since then,
many drugs have been demonstrated to have an
affinity for the melanin-containing tissues of the eye
(Brittebo & Tjalve, 1980; Castonguay, Tjalve,
Trushin, & Hecht, 1984; Domellof et al., 1987;
Roberto et al., 1996; Tjalve & Castonguay, 1983).
Drug-induced lesions in melanin-containing tissues
of the eye, inner ear, and brain stem are related to the
drug’s accumulation and retention in those tissues
(Lindquist, 1973; Lindquist & Ullberg, 1972; Lyden,
Larsson, & Lindquist, 1982; Potts, 1962). Lindquist
and colleagues noted that several drugs accumulate
in melanin for months, and that in some cases these
drugs could be retained for years (Lindquist, 1973;
Lindquist & Ullberg, 1974). Long-term exposure of
noxious chemicals may lead to high levels being
stored in melanin, which ultimately may cause
degeneration in the melanin-containing cells and
lesions developing in the surrounding tissues
(Larsson, 1993). Specific drugs shown not to have a
high affinity for melanin include buprenorphine
(Wilkins, Valdez, Nagasawa, Gygi, & Rollins,
1998), amphetamines, catecholamines (Harrison
et al., 1974), cocaine (Claffey et al., 2001; Joseph,
Hold, Wilkins, Rollins, & Cone, 1999; Joseph, Tsai,
Tsao, Su, & Cone, 1997), codeine (Gygi, Joseph,
Cone, Wilkins, & Rollins, 1996; Joseph et al., 1999),
haloperidol (Lyden et al., 1982), methadone (Green
& Wilson, 1996), and several neuroleptic drugs
(Lindquist, 1973; Lindquist & Ullberg, 1972; Potts,
1962, 1964).
Melanin’s ability to bind to drugs and chemicals
may be detoxifying and protective by absorbing
potentially harmful substances (Ortonne, 2002). One
investigator suggested that the ‘‘harmless stimulation
of the pigmentary system [skin] with chemical drugs
may prevent toxic destruction of [this] melanin-
containing tissue’’ (Hedin, 1991). However, regular
intake of nicotine, which is lipid soluble and readily
permeates cell membranes (Eliopoulos et al., 1994),
may induce the same type of lesions shown to occur
with long-term use of other drugs with an affinity for
melanin (Szuts et al., 1978), as well as other adverse
effects (Creel, 1980).
Tobacco industry documents and industry knowledge
Most of the internal tobacco industry documents we
reviewed were copies of published articles already
discussed in this review. The documents showed that
the tobacco industry funded studies of nicotine
distribution (Kastenbaum, 1975; Larsson et al.,
1979; Marlowe & Waddell, 1975; Szuts, Olsson,
Lindquist, & Ullberg, 1978; Ullberg, 1972) and
revealed industry interest in this line of research
(Anderson, Applegren, Hansson, Hoffmann, &
Schmiterlow, 1966; Council for Tobacco Research,
1983, 1984; DeBardeleben, 1988; Ford, 1977;
McKennis, 1974, 1975; H. Zahn, 1980; L. Zahn,
1974). However, we found no evidence in the
documents to date that the tobacco industry con-
sidered any potential implications of this research for
people who have higher concentrations of melanin.
Discussion
This review of the scientific literature highlights
important aspects of the relationship between nicotine
and melanin that may warrant further study. The
studies included in the review are primarily animal
studies, and interspecies differences in nicotine’s
affinity for melanin-containing tissues have been
documented (Leeds & Turner, 1977; Tsujimoto,
Nakashima, Tanino, Dohi, & Kurogochi, 1975).
Such differences may become especially critical when
attempting to predict nicotine uptake and deposition
in human tissues (Plowchalk, Andersen, & de Bethizy,
1992); thus it is premature to assert anything about
possible nicotine-melanin interactions in humans.
However, if melanin’s relationship to nicotine and
other tobacco smoke components as documented in
animals holds true in humans, there may be possible
adverse health implications for those individuals with
higher concentrations of melanin. Thus it may be
fruitful to theorize how this might occur.
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Chronic nicotine exposure from smoking is asso-
ciated with numerous adverse health consequences.
The potential accumulation in melanin-containing
tissues of nicotine and tobacco-specific compounds
may be a concern for any individual who is
chronically exposed to tobacco smoke. However,
those individuals who have higher concentrations of
melanin might be at increased risk, if it can be shown
that the retention of nicotine and tobacco-specific
carcinogens in melanin-containing tissues results in
greater exposure to these substances.
The 1988 surgeon general’s report on nicotine
addiction and its appendix on nicotine toxicity
discussed the distribution and retention of nicotine
and its metabolites in various body tissues, citing the
earlier studies on nicotine distribution (USDHHS,
1988). However, the report did not discuss possible
implications of nicotine accumulation in melanin-
containing tissues in humans.
Though it is not clear what role, if any, menthol
may play in an increased risk of cancer among
smokers of mentholated cigarettes, menthol may
enhance the absorption of nicotine and other tobacco
smoke components (Ahijevych, Gillespie, Demirci, &
Jagadeesh, 1996; Caraballo et al., 1998; Clark,
Gautam, & Gerson, 1996; Jarvik, Tashkin, Caskey,
McCarthy, & Rosenblatt, 1994; Pe´rez-Stable,
Herrera, Jacob, & Benowitz, 1998). This may
contribute to greater cancer risk either by increasing
systemic exposure to tobacco smoke toxins or by
affecting the metabolism of nicotine or tobacco
smoke carcinogens (Benowitz, Herrera, & Jacob,
2004; Brooks, Palmer, Strom, & Rosenberg, 2003;
Garten & Falkner, 2004). The present review
suggests that the tobacco smoke components nico-
tine, NNN, NNK, and benzo(a)pyrene may accu-
mulate in human melanin-containing tissues.
It may be argued that melanin’s detoxifying and
protective properties (Hedin, 1991; Ortonne, 2002;
Schallreuter, Hordinsky, & Wood, 1987) may be
advantageous to those individuals who have higher
levels of it. However, it may be equally plausible that
the possible melanin-related sequestering of nicotine
and of the tobacco-specific compounds NNN, NNK,
and benzo(a)pyrene may lead to a constant exposure
to these substances. It has been suggested that long-
term exposure of smokers to these carcinogens and
the potential cumulative damage produced in years
of smoking would be substantial (Hecht, 1999).
Many important, unanswered questions remain
about nicotine’s affinity for melanin that might
inform future research. For example, investigators
have reported that, compared with other racial/
ethnic groups, Blacks have a higher intake of nicotine
per cigarette and increased nicotine absorption
(Caraballo et al., 1998; Clark et al., 1996; Pe´rez-
Stable et al., 1998; Wagenknecht et al., 1990) and
have suggested that this higher nicotine absorption
could help explain their lower quitting rates (Centers
for Disease Control and Prevention, 1993). These
studies did not specifically address nicotine’s accu-
mulation in melanin, but if such an accumulation can
be documented in humans as it has in animals, it
could aid in understanding whether melanin-specific
differences in nicotine metabolism play a role in these
racial differences. Blacks as a group tend to have
higher levels of melanin. Furthermore, 75%–80% of
Black adult smokers consume menthol cigarettes
(Ahijevych, Tyndale, Dhatt, Weed, & Browning,
2002; Clark et al., 1996; Cummings, Giovino, &
Mendicino, 1987; Gardiner, 2004; USDHHS, 1998),
which increases their exposure to benzo(a)pyrene and
its accumulation in melanin-containing tissues.
Other questions include (a) Does the accumulation
of nicotine in melanin-containing tissues have an
impact on nicotine metabolism, the level of nicotine
dependence, or consequential health risks? and
(b) Does the sequestering of nicotine in melanin-
containing tissues prolong its half-life, thereby
leading to chronic exposure to nicotine and increased
nicotine dependence, or is it a protective mechanism
that aids in detoxification?
Interest in neuromelanin is growing. Though
neuromelanin is believed to be related to the
melanins located outside the central nervous system,
many questions remain unanswered about its struc-
ture and functions (de Marco et al., 2004; Fedorow
et al., 2005). One area that may be worthy of
exploration is the triad of melanin, nicotine, and
melatonin. Melatonin is a hormone released by the
pineal gland that has numerous cellular actions,
including inhibiting melanin synthesis (Logan &
Weatherhead, 1980; Slominski & Pruski, 1993) and
modifying dopamine levels. Melatonin also has
modulating effects on many physiological, endocrine,
and behavioral functions in the brain (Cassone, 1990;
de Prado, Reiter, & Mora, 2003; Krause &
Dubocovich, 1990; Reiter, 1991), and acts on parts
of the brain that are also influenced by nicotine
(Dani & Heinemann, 1996; Paredes et al., 1999).
Nicotine has been shown to stimulate the release
of dopamine, which has been implicated in the
sensation of reward (Dani & Heinemann, 1996),
and melatonin has the ability to inhibit nicotine-
stimulated dopamine release (Schiller, Champney,
Reiter, & Dohrman, 2003). Although a review of the
melatonin-melanin-nicotine relationship is beyond
the scope of this paper, it could be relevant in teasing
out mechanisms related to nicotine absorption and
metabolism.
An extensive literature suggests that nicotine and
tobacco-specific compounds may accumulate in
tissues containing melanin and that this retention
may affect melanin synthesis. Existing work lacks an
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adequate consideration of the potential impact, if
any, of this phenomenon on nicotine metabolism,
level of nicotine dependence, and cessation success.
Speculatively, could accumulation of nicotine and
tobacco-specific compounds in melanin-containing
tissues be relevant in developing better models to
explain tobacco-related health disparities affecting
some communities of color?
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